Abcellera Biologics Inc is trading at $5.12 (5.5% down) amid a broader risk-off environment that is pressuring growth and tech-oriented names.
- The decline aligns with significant weakness in major indices, with the S&P 500 down 1.39% and the Nasdaq Composite falling 2.21%.
- There are no fresh company-specific catalysts or analyst actions this morning, suggesting the move is driven by amplified volatility in higher-beta stocks.